Answer
Baraclude (entecavir) should not be used during pregnancy unless clearly necessary because adequate pregnancy data are lacking, animal studies showed reproductive toxicity at high doses and human risk is unknown; appropriate interventions should prevent neonatal HBV acquisition because effects on mother-to-infant transmission are unknown.
Sources for this answer
- Baraclude 0.05 mg/ml oral solutionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked